The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Learning Technologies confident of progress

Wed, 22nd Jun 2022 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Provexis PLC, up 16% at 1.00 pence, 12-month range 0.7p-1.15p. Enters transfer of business agreement and a premix and market-ready solutions supply agreement for heart-health functional food ingredient Fruitflow, both with effect from the start of 2023, after talks with DSM Nutritional Products to replace their alliance agreement which runs to the end of 2022. Also files new patent application relating to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans.

----------

Learning Technologies Group PLC, up 4.7% at 114.4p, 12-month range 105p-239p. Reports continuation of strong business momentum into the first half of 2022. The London-based digital learning and talent management services provider says the acquisition of GP Strategies has progressed ahead of plan, providing the expanded company with a platform to gain a further stake in the digital learning and talent management market. "While mindful of the current macro environment, strong business momentum has continued into the first half of 2022 and we have a robust balance sheet that will support further strategic acquisitions in due course, underpinning the board's confidence of significant progress," says Chair Andrew Brode.

----------

AIM - LOSERS

----------

Corcel PLC, down 13% at 0.8961p, 12-month range 0.9p-2.2p. The mining and mineral resource development company says all parties have mutually agreed to end the company's marketing rights and the funding efforts associated with the Avonmouth project. The company and Altana, given the "strong bias of Altana and investors more generally" towards non fossil fuel projects, will now focus on energy storage opportunities across the UK. "Whilst it is of course disappointing to end our negotiations on Avonmouth after many months of effort, we recognize the practical dominance of ESG sentiments with infrastructure and energy investors," says Chief Executive Scott Kaintz.

----------

Xeros Technology Group PLC, down 11% at 37.00p, 12-month range 32p-248p. The environmental technology firm says revenue for 2021 rises to GBP474,000 from GBP385,000 in 2020. Pretax loss narrows to GBP6.9 million from GBP7.6 million. Expects to achieve cash breakeven in 2024 and profitability at the earnings before interest, tax, depreciation and amortisation level.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2012 14:10

Sunday share tips: GKN, Provexis, BP

First-half numbers from specialist engineer GKN beat market expectations, with pre-tax profits leaping 43 per cent. Nigel Stein, chief executive, also gave some upbeat interviews, indicating that, while many of GKN's customers were cautious about the rest of 2012, "no one is pressing alarm buttons"

Read more
31 Jul 2012 11:51

Small caps: IndigoVision, Silence Therapeutics, Air Partner...

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring

Read more
14 Feb 2012 10:12

Small caps round-up: Provexis, CareTech, Nanoco ...

Sports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic

Read more
15 Dec 2011 15:01

Sector movers: Old Mutual boosts life insurers after Nordic sale

Life insurance stocks were on the rise on Thursday afternoon, helped by FTSE 100 savings, investment and insurance group Old Mutual. Shares in Old Mutual roared higher on Thursday after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in an effort to "reduce complexity" and p

Read more
1 Dec 2011 12:40

First half losses grow at Provexis

Medical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share price fell 23.08% to 1.75p by 13:05. The losses, which grew from £1m to £1.5m, came despite revenues doubling from £0.7m to £1.5m after costs rose signi

Read more
17 Jun 2011 09:20

Provexis hurt by R&D costs, acquisition fails to inspire

Medical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its plans to acquire a sports nutrition products manufacturer failed to inspire investors. For the year ended March 31, Provexis posted a loss before tax

Read more
16 Dec 2010 07:49

Rising R&D costs hurt Provexis

Medical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investment in R&D increased to £612,171 in the period, up from £289,125 in the same period last year, as the group broadens its product pipeline. The group

Read more
9 Sep 2010 16:23

Provexis to exhibit Fruitflow later this year

The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health. The marketing strategy for Fruitflow is now being finalised and the technology

Read more
26 Jul 2010 16:55

Provexis widens Fruitflow approvals

Functional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supplements. Fruitflow was already allowed to be used in drinks by the EFSA. Provexis can also use the claim that Fruitflow "helps maintain normal plate

Read more
26 Jul 2010 07:33

Provexis: Fruitflow Gets Further European Food Safety Approval

LONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, Monday announces a widening of the European Food Safety Authority (EFSA) opinion on the Company's

Read more
22 Jun 2010 07:33

Provexis Raises GBP88,869 In Draw Down Of Funds, Equity Issue

LONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, said Tuesday it has raised net proceeds of GBP88,869 by drawing down on its Equity Financing Facility with

Read more
31 Mar 2010 17:07

London close: Up and down day for London

The movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neither up nor down. British Sky Broadcasting (BSkyB) was predictably outraged at the decision by telecoms regulator Ofcom to order it to make its two top

Read more
31 Mar 2010 16:08

Small caps round-up: Provexis, Renew, Source BioSciences...........

Functional foods developer Provexis expects to have net cash of £7m at the end of March 2010. It has also entered into a three-year, £25m equity financing facility provided by Evolution Securities through its subsidiary Darwin Strategic. This could be used to help finance acquisitions. Renew Holdi

Read more
9 Mar 2010 08:45

Provexis surges on test results

Shares in medical food and dietary supplement developer Provexis shot up on Tuesday after it published the results of a trial of its Fruitflow product, which is designed to reduce the risk of heart attack, stroke and venous thrombosis. Fruitflow, a tomato extract which counters unwanted clot forma

Read more
17 Dec 2009 12:03

Small cap round-up: ILX, Ideal Shopping, Provexis...

E-learning company ILX has won three contracts that are expected to produce revenues of more than £0.27m over the life of the contracts. The first contract is to provide project management training to a major government department over a period of three years. The other two contracts are for overse

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.